{
  "docId": "019de074-1527-7308-955d-4c9eab2bbacb",
  "docSlug": "e812f3c221148b99b15c4527dea8f94b",
  "documentTitle": "argenx SE | Results Presentation Deck | 15 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 15,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 48,
  "notes": "Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-1527-7308-955d-4c9eab2bbacb/6",
  "deckHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb",
  "deckJsonHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb.json",
  "deckAnchorHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.08,
        "y": 0.92
      },
      "kind": "disclaimer",
      "text": "Safety Analysis Set. ITP = immune thrombocytopenia; SD = standard deviation; TPO-RA = thrombopoietin receptor agonists; WHO = World Health Organization.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "260bc09f-97c0-438a-8ef5-a997c4ddebca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.72,
        "w": 0.85,
        "x": 0.08,
        "y": 0.18
      },
      "kind": "table",
      "text": "Baseline characteristics table comparing Efgartigimod (n=86) and Placebo (n=45) across age, gender, diagnosis time, splenectomy, WHO bleeding score, and prior therapies.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06f2c99a-1c51-4a9b-8f6a-8b214f92939b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.08,
        "y": 0.05
      },
      "kind": "title",
      "text": "Baseline Characteristics Indicate the Majority of Participants Had Multiple Prior Therapies and Long-standing ITP",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc727aea-9864-4ba7-8ca5-e29d34c6e605",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "44cfae2d-c3bc-4381-9103-a4632e118ac7",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitation",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Baseline characteristics show multiple prior therapies and long-standing ITP (slide 6).",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}